# Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia

> **NCT00613457** · PHASE3 · COMPLETED · sponsor: **Associazione Italiana Ematologia Oncologia Pediatrica** · enrollment: 2039 (actual)

## Conditions studied

- Leukemia

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** asparaginase
- **DRUG:** Asparaginase
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** daunorubicin
- **DRUG:** doxorubicin
- **DRUG:** Etoposide
- **DRUG:** Ifosfamide
- **DRUG:** mercaptopurine
- **DRUG:** Methotrexate
- **DRUG:** prednisone
- **DRUG:** thioguanine
- **DRUG:** Vincristine
- **DRUG:** Vindesine

## Key facts

- **NCT ID:** NCT00613457
- **Lead sponsor:** Associazione Italiana Ematologia Oncologia Pediatrica
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 2039 (ACTUAL)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00613457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00613457, "Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00613457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*